The 2026 MPFS proposed rule includes higher conversion factors across the board. However, some cardiology groups remain concerned about a series of reimbursement reductions for high-value cardiology services. The 2026 MPFS proposed rule includes higher conversion factors across the board. However, some cardiology groups remain concerned about a series of reimbursement reductions for high-value cardiology services. | | |
|
Suman Tandon, MD, an American Society of Nuclear Cardiology board member, explains the group's call on Congress to update a number of healthcare policies. Suman Tandon, MD, an American Society of Nuclear Cardiology board member, explains the group's call on Congress to update a number of healthcare policies. | | |
|
The ongoing debate continues. The team behind this latest analysis pointed to more than 40 years of research to make its point. The ongoing debate continues. The team behind this latest analysis pointed to more than 40 years of research to make its point. | | |
|
|
Finerenone, sold by Bayer under the brand name Kerendia, is now approved in the United States for the treatment of HFmrEF and HFpEF. The drug has already been used for years to treat patients with chronic kidney disease and type 2 diabetes. Finerenone, sold by Bayer under the brand name Kerendia, is now approved in the United States for the treatment of HFmrEF and HFpEF. The drug has already been used for years to treat patients with chronic kidney disease and type 2 diabetes. | | |
|
Edwards Lifesciences has recalled more than 61,000 medical devices due to the risk of a small piece of wire becoming exposed. No patient injuries have been reported at this time. Edwards Lifesciences has recalled more than 61,000 medical devices due to the risk of a small piece of wire becoming exposed. No patient injuries have been reported at this time. | | |
|
The first FDA-cleared AI model of its kind was found to be an accurate screening tool for cardiac amyloidosis. The first FDA-cleared AI model of its kind was found to be an accurate screening tool for cardiac amyloidosis. | | |
|
The Varipulse PFA platform originally gained FDA approval in 2024. According to Johnson & Johnson MedTech, this update was put in place to help the technology provide better patient outcomes going forward. The Varipulse PFA platform originally gained FDA approval in 2024. According to Johnson & Johnson MedTech, this update was put in place to help the technology provide better patient outcomes going forward. | | |
|
|
Both base salaries and total compensation are consistently lower for women than men, according to new survey data. The disparities in cardiac surgery are often worse than those found in other healthcare specialties. Both base salaries and total compensation are consistently lower for women than men, according to new survey data. The disparities in cardiac surgery are often worse than those found in other healthcare specialties. | | |
|
Cerebral embolic protection devices are proven to work. However, according to one cardiologist, they are still not consistently reducing stroke rates. Cerebral embolic protection devices are proven to work. However, according to one cardiologist, they are still not consistently reducing stroke rates. | | |
|
A team of biomedical engineers, radiologists and cardiologists has developed a new AI model capable of restoring low-quality cardiac MRI scans. A team of biomedical engineers, radiologists and cardiologists has developed a new AI model capable of restoring low-quality cardiac MRI scans. | | |
|
|
LMI is the maker of Neuraceq, a globally approved F-18 positron emission tomography imaging agent used to detect beta-amyloid plaques in patients evaluated for Alzheimer’s. LMI is the maker of Neuraceq, a globally approved F-18 positron emission tomography imaging agent used to detect beta-amyloid plaques in patients evaluated for Alzheimer’s. | | |
|
Within healthcare, artificial intelligence and quality improvement have some things in common. Within healthcare, artificial intelligence and quality improvement have some things in common. | | |
|